Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Expert Analyses How Stress Affects Outcomes in Ovarian Cancer

November 18th 2016, 1:07am

Article

Stress and depression can alter ovarian cancer tumors, often leading to poorer outcomes.

Optimizing Neoadjuvant Chemotherapy in Ovarian Cancer

November 11th 2016, 9:34pm

Article

Optimizing the use of neoadjuvant chemotherapy could improve outcomes for patients with ovarian cancer.

Third Woman With Ovarian Cancer Wins Lawsuit Against Johnson & Johnson Over Baby Powder Safety

November 3rd 2016, 9:12pm

Article

A woman won a lawsuit against Johnson & Johnson, claiming that its baby powder caused her ovarian cancer.

Starting the Conversation: Female Cancer Survivors Face Untreated Sexual Pain

November 3rd 2016, 6:10pm

Article

Many female survivors of cancer face sexual pain after treatment, and may not feel comfortable starting a conversation with their health care providers.

PARP Inhibitor Shows Benefit in Ovarian Cancer

November 1st 2016, 9:31pm

Article

Lynparza imrpoved progresion-free survival (PFS) when compared to the placebo group in a phase 3 ovarian cancer trial.

Ovarian Cancer Recurrence: Discussion With an Expert

October 31st 2016, 10:48pm

Article

CURE spoke with Scott Richard, M.D., about ovarian cancer recurrence and barriers women may face the second time around.

New Toolkit Can Help Debunk Myths About Genetic Testing for Gynecologic Cancer

October 27th 2016, 9:13pm

Article

A new toolkit developed by the Society for Gynecologic Oncology is aimed at increasing awareness about genetic testing for gynecologic cancers.

Expert Discusses Estrogen Use in Women With BRCA Mutations

October 26th 2016, 8:16pm

Article

Mache Seibel discusses the benefits of taking estrogen supplements for women who harbor the BRCA genetic mutation.

Ovarian Cancer Trial Stopped Due to Low Response

October 18th 2016, 9:37pm

Article

A trial testing Zytiga's effectiveness in ovarian cancer was recently halted.

Phase 3 Study Data Represent 'Breakthrough' for Patients With Ovarian Cancer

October 10th 2016, 8:12pm

Article

A cohort of patients with ovarian cancer saw survival benefit with niraparib in a recent phase 3 study.